• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

188.87 -0.18 (-0.10%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
October 29, 2025
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
October 22, 2025
From Johnson & Johnson
Via Business Wire
Johnson Y-Axis Adjustment(R) (\"Ring Dinger(R)\") Clarified as In-Scope Care Under Texas Law; Advanced Chiropractic Equipment LLC Addresses Confusion with Y-Strap Traction
October 20, 2025
Houston, Texas--(Newsfile Corp. - October 20, 2025) - Advanced Chiropractic Equipment LLC (ACE) and Your Houston Chiropractor, Gregory E. Johnson,... 
Via Newsfile
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025
October 14, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
October 14, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook
October 14, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota
October 10, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
October 09, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
October 06, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors
September 08, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum
September 08, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 03, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
July 30, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
July 24, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025
July 16, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook
July 16, 2025
From Johnson & Johnson
Via Business Wire
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
July 22, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(NASDAQ:TEM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors
June 10, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
May 28, 2025
From Johnson & Johnson
Via Business Wire
FDA Panel Reiterates the Cancer Risks of Talc
May 23, 2025
From Beasley Allen Law Firm
Via Business Wire
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
May 21, 2025
From Johnson & Johnson
Via Business Wire
Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails
May 15, 2025
From Nachawati Law Group
Via Business Wire
Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 14, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson expands efforts to champion the nursing workforce globally
May 08, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
April 28, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
April 16, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%
April 15, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q1 2025 Results
April 15, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference
April 07, 2025
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
April 02, 2025
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap